Atrioventricular block after transcatheter ASD closure using the Amplatzer septal occluder: risk factors and

Shada J Al-Anani1, Howard Weber, Ziyad M Hijazi

  • 1Department of Pediatrics and Medicine, Rush Center for Congenital and Structural Heart Disease, Rush University Medical Center, Chicago, Illinois 60612, USA.

Insights

Transcatheter device closure for atrial septal defects (ASD) is effective but can rarely cause atrioventricular block. Surgical removal of the device resolved this rare complication in two patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Transcatheter device closure is a safe and effective alternative to surgical repair for atrial septal defects (ASD).
  • While generally associated with lower complication rates than surgery, arrhythmias can occur as infrequent complications of device closure.
  • Complete heart block is a rare but serious complication of both surgical and transcatheter closure of ASDs.

Observation:

  • Two patients developed atrioventricular (AV) block within 48 hours of uncomplicated transcatheter ASD closure using the Amplatzer septal occluder (ASO) device.
  • Medical management with high-dose steroids and non-steroidal anti-inflammatory agents proved inadequate in both cases.
  • Both patients required surgical removal of the ASO device to resolve the AV block.

Findings:

  • Complete resolution of atrioventricular conduction abnormalities was achieved after surgical device removal.
  • The study highlights AV block as a rare but significant complication following transcatheter ASD device closure.
  • Prompt surgical intervention may be necessary for refractory AV block post-device closure.

Implications:

  • This case series suggests that surgical removal of the ASO device can be a successful treatment for AV block after transcatheter ASD closure.
  • Understanding the etiology and risk factors for AV block is crucial for preventing and managing this complication.
  • Further research is warranted to establish optimal management strategies for AV block following transcatheter ASD device closure.